HSA — authorised 14 June 1965
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: likely_approved
🇸🇬 Maolate in Singapore
HSA authorised Maolate on 14 June 1965
Marketing authorisation
Maolate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Singapore
Frequently asked questions
Is Maolate approved in Singapore?
Yes. HSA authorised it on 14 June 1965.
Who is the marketing authorisation holder for Maolate in Singapore?
PHARMACIA AND UPJOHN holds the Singaporean marketing authorisation.